Pneumococcus is a gram-positive bacteria that can cause high morbidity diseases such as pneumonia, sinusitis, acute otitis media, bacteremia, and high mortality diseases such as meningitis, and can even lead to hemiplegia Serious sequelae such as hearing loss and nervous system damage. The World Health Organization lists pneumococcal-related diseases as diseases requiring “high priority” for vaccine prevention, and my country’s “Expert Consensus on Immunization and Prevention of Pneumococcal Diseases (2017 Edition)” also considers pneumococcal vaccination It is the most effective measure to prevent pneumococcal-related diseases in my country. Patients with chronic diseases, especially those with diabetes and chronic obstructive pulmonary disease (COPD), are more likely to be infected with pneumococcus, and have a higher probability of severe pneumonia, which brings a heavy burden to individuals, families, and society, leading to many chronic diseases The patient became impoverished due to illness and returned to poverty due to illness. Vaccination with pneumococcal vaccine can significantly reduce the risk of hospitalization and death of patients and can reduce medical expenditure, which is highly cost-effective.
The currently commonly used adult pneumococcal vaccines are mainly 23-valent polysaccharide vaccines, which can cover 23 serotypes that frequently cause pneumococcal infection. About 90% of pneumonia is caused by these 23 serotypes. Most people develop pneumococcal protective antibodies within 2-3 weeks after vaccination. The 23-valent pneumonia vaccine has been on the market for many years, with good safety and immune efficacy can be maintained for 5 years.
At present, many places in the province have provided free pneumonia vaccines for the elderly aged 60 and over. However, there are no preferential policies for pneumonia vaccine immunization for people with chronic diseases such as diabetes and chronic obstructive pulmonary disease. In order to better prevent and control chronic diseases and their complications, reduce the disease burden, and provide data support for the government to issue pneumonia vaccination policies for patients with chronic diseases. In the outpatient diagnosis and treatment services of medical institutions and the health management of chronic diseases in the community, the Chronic Disease Institute will carry out the publicity and recommendation of pneumonia vaccination for patients with chronic diseases, and explore the establishment of an appropriate pneumonia vaccination model for patients with chronic diseases, so as to reduce the disease burden and increase the number of chronic diseases. The overall health level, enhance the sense of well-being, towards common prosperity.